Information

You are on the new improved site. You can view the old site in view-only mode here until June 27, 2026

loading
Dyamic Contrast-Enhanced Magnetic Resonance Imaging Pharmacodynamic Study of Sorafenib in Metastatic Renal Cell Carcinoma: Preliminary Results of a Randomized,Phase II Trial